Results 111 to 120 of about 2,720,518 (226)

SGLT2 Inhibitors Are Associated With Suppression of the Sema3A/NRP1/Plexin‐A1 Signaling Axis in Postmenopausal Women With Type 2 Diabetes: Evidence From Propensity Score‐Matched Analysis

Journal of Diabetes, Volume 18, Issue 9, September 2026.
Propensity score‐matched comparison of 23 SGLT2 inhibitor users and 23 non‐users revealed that SGLT2 inhibitor use was associated with significantly lower Neuropilin‐1 (NRP1) levels (74.25 vs. 87.61 ng/mL; p = 0.015) and a higher Sema3A/NRP1 ratio (0.14 vs.
Sertas Erarslan, Burcu Cosgun Bora
wiley   +1 more source

Primary Hyperparathyroidism Secondary to a Sestamibi-Negative Cystic Parathyroid Adenoma. [PDF]

Cureus, 2021
Win GM, Gusov T, Marium F, Gardner MJ.
europepmc   +1 more source

Hyperparathyroidism secondary to hyperaldosteronism

, 2010
Introduction: Hyperparathyroidism has been associated with essential hypertension. In rats, volume expansion, the deoxycorticosterone (DOC)-salt hypertension model and primary aldosteronism cause a reduction in plasma calcium levels and secondary ...
Fortina F., Bellosta S.
core   +1 more source

Dual‐isotope subtraction scintigraphy and SPECT‐CT for preoperative localization of parathyroid adenomas

Clinical Physiology and Functional Imaging, Volume 46, Issue 5, September 2026.
Abstract Context Primary hyperparathyroidism (PHPT) is often caused by a parathyroid adenoma (PTA). Subtraction scintigraphy with 123I and 99mTc –MIBI SPECT‐CT, and neck ultrasound examination as a hybrid scan (HS) can be used to localize the PTA in order to promote minimally invasive surgery.
Patricia M. Udholm, Christian S. Eriksen, Sabrina H. d'Este, Pernille Bach‐Mortensen, Søren Møller   +4 more
wiley   +1 more source

A case of hyperparathyroidism secondary to tumor-induced osteomalacia. [PDF]

Zhong Nan Da Xue Xue Bao Yi Xue Ban, 2023
Yang Y, Jin P, Zhang S, Chen K, He H, Mo Z, Yuan J.   +6 more
europepmc   +1 more source

Paricalcitol for secondary hyperparathyroidism in renal transplantation

, 2015
Secondary hyperparathyroidism contributes to post-transplant CKD mineral and bone disorder. Paricalcitol, a selective vitamin D receptor activator, decreased serum parathyroid hormone levels and proteinuria in patients with secondary hyperparathyroidism.
A. Perna, K. Courville, F. Gaspari, N. Perico, A. Villa, G. Remuzzi, E. Gotti, D. Martinetti, M. Cortinovis, J. R. Loaeza, S. Prandini, C. Ferrer Siles, M. Trillini, A. Cannata, M. R. Caruso, P. Ruggenenti   +15 more
core   +1 more source

Hypophosphataemia following iron infusion: a narrative review of an increasingly recognised complication

Internal Medicine Journal, Volume 56, Issue 9, Page 1500-1509, September 2026.
Abstract Parenteral iron is widely prescribed by medical practitioners, with more than 600 000 outpatient prescriptions dispensed in 2025 through the Australian Pharmaceutical Benefits Scheme. While intravenous iron has transformed the management of iron deficiency, hypophosphataemia is now recognised as a common complication, with incidences reported ...
Brenda Ta, Stephanie Baddock, Jane Ludington, Angela Sheu   +3 more
wiley   +1 more source

Cost-effectiveness analysis of intravenous paricalcitol vs. oral calcitriol in the treatment of hyperparathyroidism secondary to chronic kidney disease. [PDF]

J Bras Nefrol, 2023
Cardoso MMA, Machado-Rugolo J, Lima SAM, Andrade LGM, Curado DSP, Ponce D.   +5 more
europepmc   +1 more source

Surgical treatment of secondary hyperparathyroidism

, 2000
BACKGROUND: Surgical treatment in the patient effected by secondary hyperparathyroidism consists in subtotal parathyroidectomy or total parathyroidectomy plus autotransplantation of parathyroid tissue.
CARACO C, CANDELA, Giancarlo, CONZO, Giovanni, GIORDANO A, VACCA R., SANTINI L   +5 more
core  

Autonomic neuropathy and secondary hyperparathyroidism in uraemia

, 1990
To evaluate the relationship between autonomic neuropathy, and biochemical and X-ray parameters of secondary hyperparathyroidism, we examined 19 predialysis and 24 haemodialysis non-diabetic uraemic patients.
SPALLONE, VINCENZA, Lungaroni, G, MENZINGER DI PREUSSENTHAL, GUIDO ENRICO, Diacinti, D, Maiello, MR, Sardella, D, Tomei, E, Coen, G., Mazzaferro, S   +8 more
core   +1 more source